Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration : additional information regarding baseline lesion composition's impact on vision outcomes-TAP report no. 3
ContributorsBressler, Neil M; Arnold, Jennifer; Benchaboune, Mustapha; Blumenkranz, Mark S; Fish, Gary E; Gragoudas, Evangelos S; Lewis, Hidel; Schmidt-Erfurth, Ursula; Slakter, Jason S; Bressler, Susan B; Manos, Kelly; Hao, Yong; Haynes, Laurie; Koester, John; Reaves, Al; Strong, Andrew; Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group
Published inArchives of ophthalmology, vol. 120, no. 11, p. 1443-1454
Publication date2002-11-01
NoteOther members of the TAP Study Group are published in Arch Ophthalmol 1999;117(10):1329-1345. Doi:10.1001/archopht.117.10.1329
Affiliation entities
Citation (ISO format)
BRESSLER, Neil M et al. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration : additional information regarding baseline lesion composition’s impact on vision outcomes-TAP report no. 3. In: Archives of ophthalmology, 2002, vol. 120, n° 11, p. 1443–1454. doi: 10.1001/archopht.120.11.1443
Main files (1)
Article (Published version)
Identifiers
- PID : unige:173760
- DOI : 10.1001/archopht.120.11.1443
- PMID : 12427056
Additional URL for this publicationhttp://archopht.jamanetwork.com/article.aspx?doi=10.1001/archopht.120.11.1443
Journal ISSN0003-9950
